Between the lines

In case you’re sitting around bored this weekend, here’s an interview with a book designer who isn’t Chip Kidd.

Here’s a blog post by Dylan Horrocks (a.k.a. one of the finest cartoonists alive and an all-around swell guy who let me crash at his home in New Zealand a few years ago) on science and art.

And here’s the introduction to a new book on Leo Strauss. I found it pretty interesting, especially when it went into the east coast vs. west coast Straussians’ rivalry. It really heated up when they popped Biggie, that’s for sure.

I hope your weekend is exciting enough that you don’t read all this stuff.

Everyone’s a critic

NYTimes movie critic A.O. Scott wonders why people go to bad movies, and why the hell he gets up in the morning:

For the second time this summer, then, my colleagues and I must face a frequently — and not always politely — asked question: What is wrong with you people? I will, for now, suppress the impulse to turn the question on the moviegoing public, which persists in paying good money to see bad movies that I see free. I don’t for a minute believe that financial success contradicts negative critical judgment; $500 million from now, “Dead Man’s Chest” will still be, in my estimation, occasionally amusing, frequently tedious and entirely too long. But the discrepancy between what critics think and how the public behaves is of perennial interest because it throws into relief some basic questions about taste, economics and the nature of popular entertainment, as well as the more vexing issue of what, exactly, critics are for.

The Hit Factory

Since I’ve been writing about the drug industry (our magazine bowed in October 1999) I’ve been hearing that we’re heading toward The Era of Personalized Medicine. This means that, as we develop more knowledge of the genome, proteome, and metabolome (you think I’m making this stuff up?), drugs will be tailored to generate greater efficacy or fewer side effects in smaller population groups.

The drug that gets touted as the advance guard in this wave is Herceptin, which can be very effective in treating breast cancer, but only in tumors that over-express the HER2 protein. Around 20% of breast cancer cases fall into this category; Herceptin isn’t effective against other tumors.

Some pharmacoeconomists contend that personalized medicine will lead to The End of the Blockbusters, as smaller patient groups translate to a cap on your “customer” base. On the other side of the spectrum is a “mass appeal” drug like Lipitor, the cholesterol treatment that sells more than twice the dollar amount of any other drug in the world and is now being tested for benefits in treating Alzheimer’s disease.

I bring this up not because I just finished that Top Companies report, but because of N’Sync.

This morning, I read a funny article adapted from the book The Long Tail by Chris Anderson (not this guy). It examines how the entertainment industry faces The Death of the Blockbuster, citing diminishing CD and movie sales figures and TV and radio ratings as indicators that the niche is where it’s at.

It’s altogether possible that NSync’s first-week record [2.4 million CDs sold] may never be broken. The band could go down in history [. . .] for marking the peak of the hit bubble — the last bit of manufactured pop to use the 20th century’s fine-tuned marketing machine to its fullest before the gears were stripped and the wheels fell off.

Music itself hasn’t gone out of favor — just the opposite. There has never been a better time to be an artist or a fan, and there has never been more music made or listened to. But the traditional model of marketing and selling music no longer works. The big players in the distribution system — major record labels, retail giants — depend on huge, platinum hits. These days, though, there are not nearly enough of those to support the industry in the style to which it has become accustomed. We are witnessing the end of an era.

His long-term economic arguments and his moralizing (near the end) are bizarrely off-kilter. For one thing, News Corp. owns MySpace. The site may offer massive “niche” opportunities, but it’s going to make cash hand over first for Murdoch & Co., both little (user fees) and big (as a promotional tool for its properties).

For another, in this era where every entertainment option is allegedly losing its hit-making power, Anderson manages to avoid any mention of the Harry Potter books and The Da Vinci Code. Both of these are such impossibly massive hits — despite the fact that more individual titles get published now than ever — that they blow a sizeable hole in the concept that we’re all moving to the margins.

It’s my contention that, while there a whole lot of factors at play in the decline of hits in the last five years, I think the biggest is that almost every blockbuster movie is crap, contemporary pop and dance music is so dull that radio stations needed to be bribed into playing it, and the current generation of TV executives were raised on the awful television of the late 1970s and 1980s.

Hits might not be as big as they once were, but they’re even more important to the entertainment industry now, given the high price of failure. I’m not saying it’s right, as it tends to lead to “safe” committee-designed projects, but in the pharmaceutical business, as in Hollywood, the big hits help defray the costs of a bazillion failures.

(The Agitator has some reflections on Anderson’s book.)

More posts about buildings and food

I came across BLDG BLOG yesterday, thanks to a link in the NY Observer. The most recent post, on the shortcomings of architectural criticism, is awfully read-worthy. It explores how an art form (and again, I’m using architecture as a stand-in for other art forms) can become too esoteric for its own good:

[S]trong and interesting architectural criticism is defined by the way you talk about architecture, not the buildings you choose to talk about.

In other words, fine: you can talk about Fumihiko Maki instead of, say, Half-Life, or Doom, or super-garages, but if you start citing Le Corbusier, or arguing about whether something is truly “parametric,” then you shouldn’t be surprised if anyone who’s not a grad student, studying with one of your friends at Columbia, puts the article down, gets in a car — and drives to the mall, riding that knotwork of self-intersecting crosstown flyovers and neo-Roman car parks that most architecture critics are too busy to consider analyzing.

All along, your non-Adorno-reading former subscriber will be interacting with, experiencing, and probably complaining about architecture — but you’ve missed a perfect chance to join in.

The mention of Adorno puts me in mind of the great essay, “Is Bad Writing Necessary?” which appeared in the late, lamented Lingua Franca a few years ago. (It took me a long time to find that article online after LF folded, but I dug it up on a Chinese site, cleaned up the typography, and saved it as a Word doc, which I present here.)

That essay explored the attraction of ‘esoteric writing’ of sorts, that use of academic jargon and deliberate obfuscation that (in my opinion) creates a closed, insulated circuit of theory that has little involvement in the real world. The writer contrasts this style of writing (as exemplified by Theodor Adorno) with the ‘windowpane’ style of George Orwell, which strove to be as unjargonistic as possible.

Even though I went to a theory-heavy undergrad institution, I ended up championing Orwell’s prose over the self-privileging of academic jargon (okay, maybe that should read, ‘Because I went to a . . .’). I understand that some concepts are awfully tricky and need plenty of work to explain, but if you can’t convey them to a reasonably intelligent person without resorting to a glossary of strange terminology, you’re probably just spinning your wheels.

(I’m not sure if the example of explaining the pick-and-roll to my wife this weekend applies, but that was an instance where, rather than resorting to basketball terminology, I used our salt and pepper shakers, a salad dressing bottle and a bottle-cap to demonstrate exactly what the p&r is. Then I explained to her how the Lakers’ terrible defensive rotation on the wing led to Tim Thomas rolling 20 feet for an unimpeded dunk.)

BLDG BLOG writer Geoff Manaugh also explores this idea of theory essentially having its head stuck up its ass:

First, early on, one of the panelists stated: “It’s not our job to say: ‘Gee, the new Home Depot sucks. . .'”

But of course it is!

That’s exactly your role; that’s exactly the built environment as it’s now experienced by the majority of the American public. “Architecture,” for most Americans, means Home Depot — not Mies Van Der Rohe. You have every right to discuss that architecture. For questions of accessibility, material use, and land policy alone, if you could change the way Home Depots all around the world are designed and constructed, you’d have an impact on built space and the construction industry several orders of magnitude larger than changing just one new high-rise in Manhattan — or San Francisco, or Boston’s Back Bay.

You’d also help people realize that their local Home Depot is an architectural concern, and that everyone has the right to critique — or celebrate — these buildings now popping up on every corner. If critics only choose to write about avant-garde pharmaceutical headquarters in the woods of central New Jersey — citing Le Corbusier — then, of course, architectural criticism will continue to lose its audience. And it is losing its audience: this was unanimously agreed upon by all of last night’s panelists.

Put simply, if everyday users of everyday architecture don’t realize that Home Depot, Best Buy, WalMart, even Tesco, Sainsbury’s, and Waitrose, can be criticized — if people don’t realize that even suburbs and shopping malls and parking garages can be criticized — then you end up with the architectural situation we have today: low-quality, badly situated housing stock, illogically designed and full of uncomfortable amounts of excess closet space.

And no one says a thing.

I’m not sure why I’ve grown so interested in architecture and buildings in the last few years. Maybe it’s because of the sorta intersection of art, commerce, and real-world-ness (it’s a building). I should probably ruminate on that for a while.

Anyway, enjoy the article.

Art Inaction

Witold Rybczynski has an article at Slate about how architects create a brand for themselves. Near the end, he brings up a point that I’d like to ponder (and would like you, dear reader, to ponder):

Most architectural careers are marked by a deliberate evolution–a slow simmer rather than a fast boil. The drive to establish their own unique brands pushes young architects to distinguish themselves early–too early. Moreover, public recognition of an architect’s particular approach–Meier’s minimalism, Stern’s traditionalism, Santiago Calatrava’s bravura–can serve to stymie the natural artistic evolution of a designer’s style.

This has me thinking about the conflicting impulses for just about any artist: how does one achieve commercial success without freezing one’s artistic development?

It brings me back to a post of mine from last year:

Years ago, the first time I phoned the critic and novelist David Gates, I asked him about the novel he was working on. He said, pretty facetiously, “I’m in a sort of bind. If it comes out like Jernigan [his first novel, which I adored], people will say I’m only capable of writing that type of book. If it comes out nothing like Jernigan, people who liked that book will complain that this one is no good.”

A few years later, when I read it, I thought, “This is pretty good, but it’s no Jernigan.” I was a little embarrassed about that reaction, but hey. I read the book again a few months ago, and enjoyed it a lot more than I remembered the first time.

So can you think of artists who’ve achieved renown, financial success and some degree of celebrity who’ve managed not get caught in that stasis?